Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from DHR

Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth, Cost Discipline

Danaher Corp (NYSE:DHR) on Tuesday reported second-quarter 2025 sales of $5.94 billion, up 3.5% year-over-year, beating the consensus of $5.84 billion.

Benzinga

Danaher’s Quarterly Earnings Preview: What You Need to Know

Danaher will release its second-quarter earnings later this month, and analysts anticipate a single-digit profit dip.

Barchart

Is Danaher Stock Outperforming the Nasdaq?

Danaher has notably underperformed the Nasdaq composite over the past year, yet analysts remain highly optimistic about the stock’s long-term prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Wall Street Bullish or Bearish on Danaher Stock?

Danaher has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

Barchart

Danaher's Q1 2025 Earnings: What to Expect

Danaher is all set to release its fiscal first-quarter earnings later this month, and analysts project a double-digit profit decline.

Barchart

Why a Rio Grande Valley hospital is helping to feed its patients

As the Edinburg facility and others seek to assist people experiencing food insecurity, state lawmakers have more than a dozen bills that could tackle Texas’ food deserts.

The Texas Tribune

Is Danaher Stock Underperforming the S&P 500?

Although Danaher has underperformed the S&P 500 Index over the past year, analysts remain bullish about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Are Wall Street Analysts Bullish on Danaher Stock?

Healthcare giant Danaher has significantly underperformed the broader market over the past year, yet analysts remain strongly bullish on the stock’s longer-term prospects.

Barchart

Danaher Earnings Preview: What to Expect

Healthcare giant Danaher is set to unveil its fourth-quarter earnings later this month and analysts expect a modest single-digit growth in earnings.

Barchart

How Is Danaher’s Stock Performance Compared to Medical Devices Stocks

Danaher has underperformed the Medical Devices industry, though Wall Street analysts remain strongly optimistic about its future prospects.

Barchart

What Are Wall Street Analysts' Target Price for Danaher Stock?

Although Danaher has underperformed relative to the broader market over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects.

Barchart

Darjeeling Himalayan Railway resumes toy train service from New Jalpaiguri-Darjeeling

Darjeeling Himalayan Railway (DHR) resumed its Toy train regular services from New Jalpaiguri station to Darjeeling on Sunday after a long gap. Read further on Dynamite News:

Dynamite News

What You Need to Know Ahead of Danaher's Earnings Release

With Danaher gearing up to release its third-quarter earnings later this month, analysts expect double-digit earnings decline.

Barchart

Danaher Stock: Is DHR Underperforming the Healthcare Sector?

Danaher recently underperformed the healthcare sector, but Wall Street analysts are moderately bullish about the stock’s prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

What to Expect From Danaher's Next Quarterly Earnings Report

Danaher is expected to release its second-quarter earnings later this month, and analysts project a double-digit bottom-line dip.

StockNews.com

3 Healthcare Stocks Benefiting From an Aging Population

The healthcare industry is poised for tremendous growth driven by the aging population and rising incidence of chronic diseases. Hence, quality healthcare stocks, Danaher (DHR), Amgen (AMGN), and DexCom (DXCM), benefiting from an aging population, might be worth looking into. Read more….

The Hindu

Impactful and meaningful research will solve problems of Indian citizens, says ICMR Director-General

Indian medical institutions aim to improve research quality and global rankings, focusing on impactful solutions for citizens' problems.

Barchart

Veralto: The Unassuming ESG Powerhouse That Will Likely Double

In the specialized field of spinoff companies, Veralto emerges as a prime investment opportunity, stemming from its recent spinoff from Danaher Corporation.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Danaher (DHR) vs. Stryker (SYK) - Analyzing Anticipated Q4 Earnings

With rapidly increasing healthcare demands, numerous technological breakthroughs, and advanced research and development, the medical industry is well-poised for remarkable growth and profitability. As medical companies Danaher (DHR) and Stryker (SYK) gear to report their fourth-quarter earnings tomorrow, let’s determine if these stocks are ideal buys ahead of earnings….

Barchart

Danaher Corp Has Unusual Stock Options Activity - Highlighting Value in DHR Stock

Danaher Corp, the biotech/life sciences products firm, has had unusual call options activity today. It highlights the value of shorting out-of-the-money "covered calls" in DHR stock as an income play.

Barchart

Buy Veralto The Spinoff from Danaher Is A Good Bet

Spinoffs and Parents in these sectors do well. 23 years of data from says that Large-cap Parents and Spinoffs within the Healthcare and Industrials sector observe a consistent trend of outperformance. This suggests that investors could see a similar trend with DHR and VLTO post-Spin.

StockNews.com

Are These 3 Medical Stocks Worth Buying?

The increased demand for healthcare services and technological advancements are poised to keep the healthcare industry buoyed in the foreseeable future. Given this backdrop, are medical stocks Danaher Corporation (DHR), IQVIA Holdings (IQV), and Bio-Rad Laboratories (BIO) worth buying now? Read on to find more….

StockNews.com

3 of the Strongest Stocks to Buy Right Now

Rekindled recession worries amid upheaval in the banking sector and the Fed’s further tightening of monetary policy could keep the stock market volatile in the near term. Given this backdrop, we think the strong growth prospects of UnitedHealth Group (UNH), Danaher Corp. (DHR), and ServiceNow (NOW) make these stocks solid…

The Independent UK

Met Police ‘missed chances to protect woman killed by ex-husband with crossbow’

Two officers binned a ‘burglary kit’ linked to the killer, discovered outside his ex-wife’s home the year before she was murdered.

StockNews.com

2 Stocks to Buy Now at Knocked-Down Prices

With steady growth in employment during November, slower but surer interest rate hikes by the Fed to fight inflation threaten to keep markets subdued and the economy sluggish next year. Therefore, it could be wise to load up on shares of businesses with robust demand and a stable growth trajectory,…

1 2 3

People

Mangeet Kaur BounsMangeet

595 stories

Steve Reitmeister

508 stories

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Verizon Communications Inc

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

the Rio Grande Valley

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.